Veille Scientifique

Patrice PIENKOWSKI
Coordinateur

 Après 3 ans de bons et loyaux services, la veille scientifique va s’arrêter ; voici les derniers articles sélectionnés à votre intention.
 
Nous avons pris cette décision difficile suite au constat d’un investissement très important pour un service rendu finalement incertain, comme l’attestent les statistiques de fréquentation de la rubrique sur ce site. 
 
Je remercie tous ceux et celles qui se sont investis dans la durée pour assurer la réussite du projet, à commencer par les responsables des groupes de veille : Emmanuel Coron (Endoscopie), Roger Faroux (Cancérologie), Pauline Jouët (Gastro-entérologie et proctologie), Stéphane Nahon (MICI), Vinciane Rebours (Pancréatologoie) et Christine Silvain (Hépatologie), mais aussi et surtout, tous les veilleurs anonymes pour la grande qualité de leur travail, leur compétence et leur persévérance.
Le travail de veille bibliographique ne disparait pas complètement malgré tout, grâce aux GastroScoops dont la fréquence va augmenter avec un objectif de diffusion hebdomadaire ; il s’agit d’un travail rédactionnel différent avec une analyse d’article plus approfondie et structurée, porteur de message important.

Restez donc fidèles à ces rubriques et visitez régulièrement le site de la SNFGE toujours très riche d’enseignements et d’informations.

Très cordialement.

Dr Patrice PIENKOWSKI

 

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS

T. APARICIO
A. LOPEZ
S. MANFREDI
Y. TOUCHEFEU

A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
P. DUKAN
N. GANNE-CARRIE
JL. PAYEN
PE. RAUTOU
D. VALLA

H. DAMON
F. CORDET
T. HIGUERO
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
P. SEKSIK

M. CAMUS-DUBOC
E. GELSI
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revuetrier par ordre décroissant Titre Date Coup de coeur Thématique
Clinical Gastroenterology and Hepatology Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis. avr. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease. mar. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Surgical Interventions and the Use of Device-Aided Therapy for the Treatment of Fecal Incontinence and Defecatory Disorders. déc. 17 4 ♥ Colo-proctologie
Clinical Gastroenterology and Hepatology Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease nov. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis. aoû. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials déc. 15 3 ♥ MICI
Clinical Gastroenterology and Hepatology Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases. mar. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology High Prevalence of Anal Canal High-Risk Human Papillomavirus Infection in Patients With Crohn's Disease. nov. 18 4 ♥ Coloproctologie
Clinical Gastroenterology and Hepatology Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study. juil. 17 2 ♥ Pancréas/Voies biliaires
Clinical Gastroenterology and Hepatology High Prevalence of Anal Canal High-Risk Human Papillomavirus Infection in Patients With Crohn's Disease. nov. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer aoû. 18 2 ♥ Pancréas/Voies biliaires
Clinical Gastroenterology and Hepatology Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis. Jan. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis. mai. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Outcomes of Endoscopic Balloon Dilation vs Surgical Resection for Primary Ileocolic Strictures in Patients With Crohn's Disease. aoû. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Level of Fecal Calprotectin Correlates With Severity of Small Bowel Crohn’s Disease, Measured by Balloon-assisted Enteroscopy and Computed Tomography Enterography Jan. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With Colitis. mai. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases Jan. 18 4 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of Rectal Cancer After Colectomy for Patients With Ulcerative Colitis: A National Cohort Study juil. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-ana aoû. 18 3 ♥ Pancréas/Voies biliaires
Clinical Gastroenterology and Hepatology No Association Between Consumption of Sweetened Beverages and Risk of Later-Onset Crohn's Disease or Ulcerative Colitis. Jan. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of Infliximab. aoû. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines. Jan. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression juin. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Sub-clinical Inflammation in the Proximal Colon. Jan. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis juil. 17 3 ♥ MICI

Pages